Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NALDEBAIN for Postoperative Pain in Anastomosis Takedown
NCT03854851Phase 4Unknown
- Sponsor
- China Medical University Hospital
- Start
- Mar 2019
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dinalbuphine sebacate in postoperative pain (2 arms), sponsored by China Medical University Hospital. Primary endpoint: Dosage of supplemental analgesics. Status: unknown.
02
Drugs
dinalbuphine sebacate
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03854851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03854851.